Clinical Evidence: GLP-1 and Cardiovascular Health Major clinical trials including SUSTAIN-6 (semaglutide) and SURPASS (tirzepatide) documented cardiovascular outcomes in patients with type 2 diabetes and obesity
State of the art and considerations about the risk of infection
Symptoms may include: Rash or hives Itching/swelling of face, tongue, or throat Severe dizziness Difficulty breathing Side Effect 4: Cardiovascular Concerns Some patients may experience cardiovascular-related side effects, including irregular heartbeat and chest pain
Remarkably, oral intake of Pycnogenol led to a significant increase of hair density of 30%, compared to baseline and of 15% compared to placebo after two months
Reach out to us at 949-460-9111
Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA et al